Coming Soon: GI Cancers (ASCO 2024)

Coming Soon: GI Cancers (ASCO 2024)

UPCOMING Join us forour roundtable in||latest advances in||your questions on||new therapies for||practice changes in||your patient cases in GI Cancers (ASCO 2024) Sara De Dosso ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND Thibaud Koessler Geneva University Hospitals,...
Lung Cancer (ASCO 2024)

Lung Cancer (ASCO 2024)

Agenda Welcome & introduction by host Alfredo Addeo WHAT’S NEW IN TARGETED THERAPIES FOR NSCLC? XIUNING LE LATEST INSIGHTS IN ADCS FOR LUNG CANCER LIZZA HENDRIKS NEW ADVANCES IN IMMUNOTHERAPIES FOR LUNG CANCER ALFREDO ADDEO  } 1 h 32 min Get Your CME...
Prostate & Urothelial Cancer

Prostate & Urothelial Cancer

Prostate & Urothelial Cancer Welcome & introduction by host Aurelius Omlin How to integrate the new treatment options in mHSPC and mCRPC Deborah Mukherji First-line mUC: how to manage patients on the enfortumab-pembrolizumab combination Alison Birtle Open...
Biomarkers in GI & Lung

Biomarkers in GI & Lung

Biomarkers in GI & Lung The Significance of Biomarkers in GI Oncology for My Therapy Decision Sara De Dosso Biomarkers in GI Oncology: The Tests We Perform in Gastric and GEJ Today Rupert Langer Current Standards in in Lung Cancer Therapy: Which Biomarkers We...
Breast Cancer 2023 Review

Breast Cancer 2023 Review

Breast Cancer 2023 Review Welcome & introduction by host Peter Dubsky Early breast cancer and local therapies Peter Dubsky Latest advances with antibody-drug conjugates and immunotherapies Nadia Harbeck Highlights of 2023 in endocrine and combination therapies Khalil...